Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma.
Yanqiu ZhangYaling LiHongwei YanPublished in: Clinical, cosmetic and investigational dermatology (2023)
to be poor prognostic markers, enabling immunosuppressive cell infiltration in melanoma.